Paul Tudor Jones Calliditas Therapeutics Ab Transaction History
Tudor Investment Corp Et Al
- $15.5 Billion
- Q1 2024
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Calliditas Therapeutics Ab stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 65 shares of CALT stock, worth $2,523. This represents 0.0% of its overall portfolio holdings.
Number of Shares
65Holding current value
$2,523% of portfolio
0.0%Shares
6 transactions
Others Institutions Holding CALT
# of Institutions
24Shares Held
871KCall Options Held
1.5KPut Options Held
32.4K-
Bvf Inc San Francisco, CA750KShares$29.1 Million0.47% of portfolio
-
Deutsche Bank Ag\ Frankfurt Am Main, 2M50.6KShares$1.96 Million0.0% of portfolio
-
Ironwood Investment Management LLC Boston, MA25.5KShares$990,5920.27% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il14.6KShares$566,6850.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA10.3KShares$399,0550.0% of portfolio
About Calliditas Therapeutics AB
- Ticker CALT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,624,800
- Market Cap $1.03B
- Description
- Calliditas Therapeutics AB (publ), a clinical-stage biopharmaceutical company, focused on identifying, developing, and commercializing pharmaceuticals products for treatments in orphan indications with initial focus on renal and hepatic diseases. It offers Nefecon, an oral formulation of budesonide that is an immunosuppressant for the treatment ...